64
Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Neurocognitive Disorders Chapter 22 Chapter 22

Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Embed Size (px)

Citation preview

Page 1: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Neurocognitive DisordersNeurocognitive DisordersChapter 22Chapter 22

Page 2: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

IntroductionIntroduction

• Neurocognitive disorders are disorders in which a clinically significant deficit in cognition or memory exists representing a significant change from a previous level of functioning.

Page 3: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• The number of people with neurocognitive disorder is growing because more people now survive into the high-risk period for the disorder, which is age 65 and beyond.

Introduction Introduction (cont.)(cont.)

Page 4: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

DeliriumDelirium

• Delirium is characterized by a disturbance in level of awareness and a change in cognition that develops rapidly over a short period.

Page 5: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Symptoms

– Difficulty sustaining and shifting attention– Extreme distractibility– Disorganized thinking– Speech that is rambling, irrelevant, pressured, and

incoherent– Impaired reasoning ability and goal-directed

behavior– Disorientation to time and place

Delirium Delirium (cont.)(cont.)

Page 6: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Symptoms (cont.)– Impairment of recent memory– Misperceptions about the environment, including

illusions and hallucinations– Disturbance in level of consciousness, with

interruption of the sleep-wake cycle– Psychomotor activity that fluctuates between

agitation and restlessness and a vegetative state– Emotional instability

Delirium Delirium (cont.)(cont.)

Page 7: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Symptoms include autonomic manifestations such as:– Tachycardia– Sweating– Flushed face– Dilated pupils – Elevated blood pressure

Delirium Delirium (cont.)(cont.)

Page 8: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Usually begins abruptly• Can have a slower onset if underlying etiology

is systemic illness or metabolic imbalance• Duration is usually brief

and subsides completely on recovery from underlying determinant

Delirium Delirium (cont.)(cont.)

Page 9: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Predisposing FactorsPredisposing Factors

• Delirium Due to a General Medical Condition– Examples • Infections, febrile illness, metabolic disorders, head

trauma, seizures, migraine headaches, brain abscess, stroke, electrolyte imbalance, others

Page 10: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Substance-Induced Delirium– May be caused by intoxication or withdrawal from

certain substances such as:• Anticholinergics, antihypertensives, corticosteroids,

anticonvulsants, analgesics, and others• Alcohol, amphetamines, cannabis, cocaine,

hallucinogens, inhalants, and others• Toxins, including organic solvents and fuels, lead,

mercury, arsenic, carbon monoxide, and others

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 11: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Neurocognitive Disorder Neurocognitive Disorder

• Impairment in the cognitive functions of thinking, reasoning, memory, learning, and speaking

Page 12: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Neurocognitive disorder (NCD) may be classified as mild or major, depending on severity of symptoms.

• Mild NCD has also been called mild cognitive impairment.

• Major NCD constitutes what was previously described in the DSM as dementia.

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 13: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Primary NCDs are those in which the disorder itself is the major sign of some organic brain disease not directly related to any other organic illness (e.g., Alzheimer’s disease)

• Secondary NCDs are caused by or related to another disease or condition (e.g., HIV disease or cerebral trauma)

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 14: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Symptoms – Impairment exists in abstract thinking,

judgment, and impulse control.– Conventional rules of social conduct are

disregarded.– Personal appearance and hygiene are

neglected.

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 15: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Symptoms (cont.)– Language may or may not be affected.– Personality change is common.

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 16: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Reversible NCD may be more appropriately termed temporary.

• It can occur as a result of: – Stroke– Depression– Side effects of medications– Nutritional deficiencies– Metabolic disorders

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 17: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• As the disease progresses, symptoms may include:– Aphasia – Apraxia– Irritability and moodiness, with sudden outbursts

over trivial issues– Inability to care for personal needs independently– Wandering away from the home – Incontinence

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 18: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Alzheimer’s disease (AD) accounts for 50 to 60 percent of all cases of NCD.– AD can be described in stages:• Stage 1. No apparent symptoms• Stage 2. Forgetfulness• Stage 3. Mild cognitive decline

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 19: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

– Stages of Alzheimer’s disease (cont.):• Stage 4. Mild-to-moderate cognitive decline• Stage 5. Moderate cognitive decline• Stage 6. Moderate-to-severe cognitive decline• Stage 7. Severe cognitive decline

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 20: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

1. Hospitalized and diagnosed in the fourth stage of NCD due to Alzheimer’s disease, a client, when asked about the previous evening, describes a wonderful evening spent on a cruise. Which symptom is the client exhibiting?

A. AphasiaB. ConfabulationC. DeliriumD. Apraxia

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 21: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Correct answer: B– Confabulation is a behavioral reaction to memory

loss in which the client fills in memory gaps with information about events that have not occurred. During the fourth stage of Alzheimer’s dementia, a client will use confabulation in an effort to maintain self-esteem.

Neurocognitive Disorder Neurocognitive Disorder (cont.)(cont.)

Page 22: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Predisposing FactorsPredisposing Factors

• NCD Due to Alzheimer’s Disease– Onset is slow and insidious.– Course of the disorder is generally progressive

and deteriorating.

Page 23: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Alzheimer’s Disease (cont.)– Etiologies may include:• Acetylcholine alterations• Plaques and Tangles• Head trauma• Genetic factors

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 24: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

2. A client is newly diagnosed with second stage NCD due to Alzheimer’s disease. Which cognitive change would a nurse observe?

A. Memory disturbanceB. ConfabulationC. ApraxiaD. Inability to plan or organize

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 25: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Correct answer: A– In the second stage of the illness, losses in short-

term memory are common and the individual may begin to lose things or forget names of people. It’s at this stage that a diagnosis may be considered.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 26: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Vascular NCD– NCD occurs as a result of significant

cerebrovascular disease.– There is a more abrupt onset than is seen in

association with Alzheimer’s disease, and the course is more variable.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 27: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Vascular NCD (cont.)– Etiologies may include:• Hypertension• Cerebral emboli• Cerebral thrombosis

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 28: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Frontotemporal NCD– Occurs as a result of shrinking of the frontal and

temporal anterior lobes of the brain– Previously called Pick’s disease– Exact cause is unknown, but genetics appears to

be a factor

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 29: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Traumatic Brain Injury– Amnesia is the most common neurobehavioral

symptom following head trauma.– Repeated head trauma can result in dementia

pugilistica with symptoms of:– Emotional liability– Dysarthria– Ataxia– Impulsivity

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 30: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Lewy Body Disease– Similar to Alzheimer’s disease, but progresses

more rapidly– Appearance of Lewy bodies in the cerebral cortex

and brainstem– Progressive and irreversible– May account for 25 percent of all NCD cases

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 31: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Parkinson’s Disease– This is caused by a loss of nerve cells located in

the substantia nigra and a decrease in dopamine activity.

– Cerebral changes in NCD due to Parkinson’s disease sometimes resemble those of Alzheimer’s disease.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 32: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to HIV Infection– Caused by brain infections with opportunistic

organisms or by the HIV-1 virus directly.– Symptoms may range from barely perceptible

changes to acute delirium to profound cognitive impairment.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 33: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Substance-Induced NCD– Occurs as a result of reactions to, or the overuse

or abuse of, substances such as:• Alcohol• Inhalants• Sedatives, hypnotics, and anxiolytics• Medications that cause anticholinergic site effects• Toxins, such as lead and mercury

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 34: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Huntington’s Disease– This disease is transmitted as a Mendelian

dominant gene.– Damage occurs in the areas of the basal ganglia

and the cerebral cortex.– The client usually declines into a profound state

of cognitive impairment and ataxia.– Average course of the disease is based on age at

onset, with juvenile-onset and late-onset having the shortest duration.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 35: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Prion Disease– The disorder is attributable to prion disease (e.g.,

Creutzfeldt-Jakob disease or bovine spongiform encephalopathy).

– Onset of symptoms typically occurs between ages 40 and 60 years; course is extremely rapid with progression from diagnosis to death in less than 2 years.

– Five to 15 percent of cases have a genetic component.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 36: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD Due to Another Medical Condition‒ Hypothyroidism‒ Hyperparathyroidism‒ Pituitary insufficiency‒ Uremia‒ Encephalitis‒ Brain tumor‒ Pernicious anemia‒ Thiamine deficiency‒ Multiple sclerosis

‒ Pellagra‒ Uncontrolled epilepsy‒ Cardiopulmonary

insufficiency‒ Fluid and electrolyte

imbalances‒ CNS and systemic infections‒ Systemic lupus

erythematosus

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 37: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

3. Which statement is true about vascular NCD?

A. Vascular NCD is reversible.B. Vascular NCD is characterized by plaques and

tangles in the brain.C. Vascular NCD involves a gradual, progressive

cognitive deterioration.D. Vascular NCD involves a variable pattern of

cognitive functioning.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 38: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Correct answer: D– In vascular NCD, clients suffer the equivalent of small

strokes that destroy many areas of the brain. The pattern of deficits is variable, depending on which regions of the brain have been affected.

Predisposing Factors Predisposing Factors (cont.)(cont.)

Page 39: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Application of the Nursing Application of the Nursing Process/AssessmentProcess/Assessment

• The Client History– Areas of concern to be addressed:• Type, frequency, and severity of mood swings • Personality and behavioral changes • Catastrophic emotional reactions• Cognitive changes • Language difficulties

Page 40: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• The Client History (cont.)– Areas of concern to be addressed (cont.)• Orientation to person, place, time, and situation• Appropriateness of social behavior• Current and past use of medications, drugs, and

alcohol• Possible exposure to toxins• Client and family history of specific illnesses

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 41: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Physical Assessment– Assessment for diseases of various organ systems

that can induce confusion, loss of memory, and behavioral changes

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 42: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Physical Assessment (cont.)– Neurological examination to assess mental status,

alertness, muscle strength, reflexes, sensory perception, language skills, and coordination

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 43: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Physical Assessment (cont.)– Psychological tests to differentiate between

NCD and pseudodementia (depression)

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 44: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Diagnostic Laboratory Evaluations– Include blood and urine to test for the following:• Various infections• Hepatic and renal dysfunctions• Diabetes or hypoglycemia• Electrolyte imbalances• Metabolic and endocrine disorders• Nutritional deficiencies• Presence of toxic substances

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 45: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Other diagnostic evaluations may include:– Electroencephalogram (EEG)– Computed tomography (CT) scan– Positron emission tomography (PET)– Magnetic resonance imaging (MRI)– Lumbar puncture to examine cerebrospinal

fluid (CSF)

Application of the Nursing Application of the Nursing Process/Assessment Process/Assessment (cont.)(cont.)

Page 46: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Nursing Diagnosis/Outcome Nursing Diagnosis/Outcome IdentificationIdentification

• Risk for trauma • Disturbed thought processes• Impaired memory• Disturbed sensory perception• Risk for other-directed violence• Impaired verbal communication• Self-care deficit• Situational low self-esteem• Grieving

Page 47: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Outcome CriteriaOutcome Criteria

• The Client:– Has not experienced physical injury.– Has not harmed self or others.– Has maintained reality orientation to the best

of his or her capability.– Discusses positive aspects about self and life.– Participates in activities of daily living with

assistance.

Page 48: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Planning/ImplementationPlanning/Implementation

• Care plan for the client with a cognitive disorder is aimed at:– Protection of self and others– Maintaining orientation to reality to the best of

client’s ability– Minimizing confusion– Fulfilling basic needs– Assisting and educating prospective caregivers

about appropriate care for the client

Page 49: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Client/Family EducationClient/Family Education

• Nature of the Illness– Possible causes– What to expect– Symptoms

Page 50: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Management of the Illness– Ways to ensure client safety– How to maintain reality orientation– Provide assistance with activities of daily living– Nutritional information– Difficult behaviors– Medication administration– Matters related to hygiene and toileting

Client/Family Education Client/Family Education (cont.)(cont.)

Page 51: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Support Services– Financial assistance– Legal assistance– Caregiver support groups– Respite care– Home health care

Client/Family Education Client/Family Education (cont.)(cont.)

Page 52: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Nursing Process: EvaluationNursing Process: Evaluation

• Based on the accomplishment of outcome criteria

Page 53: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

Medical Treatment ModalitiesMedical Treatment Modalities

• Delirium– Determination and correction of the underlying

causes– Staff to remain with client at all times to monitor

behavior and provide reorientation and assurance

Page 54: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Delirium (cont.)– Room with low stimulus level – Low-dose antipsychotic agents to relieve agitation

and aggression– Benzodiazepines commonly used when etiology is

substance withdrawal

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 55: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD– Primary consideration is given to etiology,

with focus on identification and resolution of potentially reversible processes.

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 56: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• NCD (cont.)– Pharmaceutical agents• For cognitive impairment:– Physostigmine (Antilirium)– Donepezil (Aricept)– Rivastigmine (Exelon) – Galantamine (Razadyne)– Memantine (Namenda)

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 57: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

– Pharmaceutical agents for NCDs (cont.)• For agitation, aggression, hallucinations, thought

disturbances, and wandering:– Risperidone (Risperdal)–Olanzapine (Zyprexa)–Quetiapine (Seroquel)– Ziprasidone (Geodon)

– These drugs cause fewer anticholinergic and EPS than older antipsychotics.

– They carry a black-box warning that all antipsychotics are associated with an increased risk of death in elderly patients with NCD.

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 58: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

‒ Pharmaceutical agents for NCDs (cont.)• For agitation, aggression, hallucinations, thought

disturbances, and wandering (cont.):

– Haloperidol (Haldol)• Still commonly used because of its proven

efficacy• Higher potential for anticholinergic, EPS, and

sedative effects than with the atypical antipsychotics

• Carries black-box warning that it is associated with increased risk of death in elderly patients with NCD

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 59: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

4. A client has recently been diagnosed with mild to moderate NCD due to Alzheimer’s disease. Which medication would the nurse expect the physician to order for this client’s cognitive impairment?

A. Nortriptyline (Pamelor)B. Zaleplon (Sonata)C. Donepezil (Aricept)D. Quetiapine (Seroquel)

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 60: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

• Correct answer: C– Donepezil is used to improve cognition in clients

diagnosed with mild to moderate dementia associated with Alzheimer’s disease. Its action improves cholinergic function by inhibiting acetylcholinesterase.

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 61: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

‒ Pharmaceutical agents for NCDs (cont.)• For depression:

– SSRIs• Often considered first line due to favorable side

effect profile– Tricyclic antidepressants• Often avoided due to anticholinergic and cardiac

side effects– Trazodone (Desyrel)• Good choice for clients with insomnia

– Dopaminergic agents• Helpful in treatment of severe apathy

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 62: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

‒ Pharmaceutical agents for NCDs (cont.)• For anxiety (should not be used routinely for prolonged

periods):– Chlordiazepoxide (Librium)– Alprazolam (Xanax)– Lorazepam (Ativan)– Oxazepam (Serax)– Diazepam (Valium)

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 63: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

‒ Pharmaceutical agents for NCDs (cont.)• For sleep disturbances (for short-term therapy only):

– Flurazepam (Dalmane)– Temazepam (Restoril)– Triazolam (Halcion)– Zolpidem (Ambien)– Zaleplon (Sonata)– Ramelteon (Rozerem)– Eszopiclone (Lunesta)– Trazodone (Desyrel)– Mirtazapine (Remeron)

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)

Page 64: Copyright © 2014. F.A. Davis Company Neurocognitive Disorders Chapter 22

Copyright © 2014. F.A. Davis Company

‒ Pharmaceutical agents for NCDs (cont.)• Dosage adjustments with regard to physiological

changes in aging clients must be made with all medications.

Medical Treatment ModalitiesMedical Treatment Modalities (cont.) (cont.)